The nod allows Hernexeos (zongertinib) to be used as an initial treatment option for NSCLC with HER2-activating mutations in ...
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and ...
Takeda ( TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the ...
NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of ...
Abstract: Leakage power is currently the most important factor in determining whether a circuit is a suitable for lowpower VLSI circuit or not. There are numerous methods to decrease power dissipation ...
Abstract: In recent years, lossy compression of hyperspectral images (HSIs) for spaceborne applications has garnered significant attention. The limited storage capacity and constrained transmission ...
In today’s automation landscape, there’s a critical junction where servo motors meet driven components, and it’s here that system performance either soars or stumbles. Flexible beam couplings have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results